Robert Castro, MD | |
Condominio La Palma Peral #14, Suite 2-g, Mayaguez, PR 00680 | |
(787) 834-2994 | |
(787) 986-7070 |
Full Name | Robert Castro |
---|---|
Gender | Male |
Speciality | Interventional Pain Management |
Experience | 37 Years |
Location | Condominio La Palma Peral #14, Mayaguez, Puerto Rico |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548368459 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 9945 (Puerto Rico) | Secondary |
208VP0014X | Pain Medicine - Interventional Pain Medicine | 9945 (Puerto Rico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Robert Castro, MD 421 Calle Juanita, Urb. Bellas Lomas, Mayaguez, PR 00682-7568 Ph: (787) 834-2994 | Robert Castro, MD Condominio La Palma Peral #14, Suite 2-g, Mayaguez, PR 00680 Ph: (787) 834-2994 |
News Archive
Profil Institute for Clinical Research, an clinical research organization (CRO) focused on diabetes, obesity and NAFLD/NASH, announced today a strategic collaboration with Gubra ApS, a metabolic preclinical and drug discovery company, to combine expertise and resources to discover and translate into clinical research novel drug targets, compounds and biomarkers addressing metabolic disease.
OPKO Health, Inc. today announced the development of a simple diagnostic blood test for Alzheimer's disease. The test, designed to detect elevated levels of antibodies unique to Alzheimer's disease, was approximately 95% accurate in initial testing.
The following joint statement, by the National Coordinator for Health Information Technology, David Blumenthal, M.D., M.P.P., and the Centers for Medicare & Medicaid Services' Principal Deputy Administrator Marilyn Tavenner, was issued today at a forum, "Accelerating Electronic Health Records Adoption and Meaningful Use."
Yesterday (8th May 2018), the Government of the Democratic Republic of the Congo declared a new outbreak of Ebola in the rural northwest of the country. This came after two cases of Ebola were confirmed in regions of Bikoro.
Almost half of all medicines globally are used irrationally. This, say medicines experts at the World Health Organization (WHO), can have severe consequences: adverse drug reactions, drug resistance, protracted illness and even death. In addition, the financial cost incurred by individuals and governments due to irrational use is unnecessary and often extremely high, particularly in developing countries where patients often pay for medicines out of pocket.
› Verified 4 days ago